购物车摘要

购物车里还没有商品。

WHI-P131

SKU: orb1306654

描述

JANEX-1

研究领域

Cell Biology, Immunology & Inflammation, Stem Cell & Developmental Biology

图片与验证

−

关键属性

−
CAS 号202475-60-3
MW333.78
纯度>98%
分子式C16H15N3O3 · HCl
SMILESCOc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC
靶点Kinase
溶解性Soluble in DMSO (up to 50 mg/ml).

生物活性

−
靶点 IC50
JAK3:78 μM
体内
JANEX-1 is administered in doses from 5 to 100 mg/kg, showing a dose-response relationship with an ED50 of 7.44 mg/kg, significantly reducing CPK and LDH levels in mice. These mice also exhibit a notably smaller infarct size (30.16±2.79%) compared to I/R-operated mice (65.64±3.76%). JANEX-1, also known as WHI-P131, is quickly absorbed, reaching peak plasma concentration in roughly 24.7±1.7 minutes, and has a short elimination half-life of 45.6±5.5 minutes. Despite the maximum plasma concentration being only half of what is observed with intravenous (i.v.) administration at the same dose, intraperitoneal (i.p.) bioavailability stands at 94.6%, with systemic exposure levels (AUC) closely matching those seen after i.v. injection (17.1±2.2 μM·h versus 18.1±1.2 μM·h).
体外
JANEX-1 (WHI-P131) exhibits strong inhibitory activity against JAK3 with an IC50 value of 78 μM, while showing no inhibitory effects on JAK1, JAK2, and various tyrosine kinases including SYK, BTK, LYN, and the insulin receptor kinase, even at concentrations up to 350 μM. It specifically induces apoptosis in human leukemia cell lines expressing JAK3 (NALM-6 and LC1;19) without affecting melanoma (M24-MET) or squamous carcinoma (SQ20B) cells. Furthermore, WHI-P131 effectively suppresses the clonogenic growth of several JAK3-positive leukemia cell lines (DAUDI, RAMOS, LC1;19, NALM-6, MOLT-3, and HL-60) in a concentration-dependent manner, with EC50 values of 24.4 μM and 18.8 μM for NALM-6 and DAUDI cells respectively, achieving more than 99% inhibition of colony formation at 100 μM. However, it does not impede the clonogenic proliferation of JAK3-negative cancer cell lines such as BT-20 breast cancer, M24-MET melanoma, or SQ20B squamous carcinoma.
细胞研究
JANEX-1 (WHI-P131) is dissolved in DMSO and stored, and then diluted with appropriate media (DMSO 0.1%) before use. The following cell lines are used in various biological assays: NALM-6 (pre-B-ALL), LC1;19 (pre-B-ALL), DAUDI (B-ALL), RAMOS (B-ALL), MOLT-3 (T-cell ALL), HL60 (acute myelogenous leukemia), BT-20 (breast cancer), M24-MET (melanoma), SQ20B (squamous cell carcinoma), and PC3 (prostate cancer). These cell lines are maintained in culture. Cells are seeded in six-well tissue culture plates at a density of 50×104 cells/well in a treatment medium containing various concentrations of JANEX-1 (0.1, 0.2, 0.3, 0.4 and 0.5 nM) and incubated for 24-48 h at 37°C in a humidified 5% CO2 atmosphere. Cells are examined for apoptotic changes after treatment with JANEX-1 by the in situ TdT-mediated dUTP end-labeling assay using the ApopTag apoptosis detection kit.

储存与操作

−
储存-20°C
有效期12 months from date of receipt.
免责声明For research use only

别名

−
JANEX-1

相似产品

−
  • WHI-P131 [orb321976]

    ≥99%

    202475-60-3

    333.77

    C16H15N3O3 HCl

    50 mg, 250 mg
  • JANEX-1 hydrochloride [orb2646118]

    188829-39-2

    333.77

    C16H16ClN3O3

    25 mg, 100 mg, 50 mg
  • WHI-P131 [orb1225745]

    >98% (HPLC)

    202475-60-3

    297.31

    C16H15N3O3

    2 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 500 mg, 1 g
质量保证

质量保证

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our 条款与条件和选购指南.

关键属性

−
暂无计算属性。

实验方案信息

可选规格

请在下方选择规格

100 mg
¥ 7,020.00
250 mg
¥ 12,480.00
1 g
¥ 24,440.00
发货Usually dispatched within 5-10 working days
批量询价